The Modular PreTargit® Platform Enables RIT for Hard-to-Treat Cancers by Significantly Improved Therapeutic Indexes
Time: 1:00 pm
day: Day 1 - Track B (PM)
Details:
• PreTargit Radioimmunotherapies
• Analysing antibody design
• Efficacy of PRIT on mouse models of colorectal and pancreatic cancer
